Cancer Research Racing Ahead Of Scientific Literacy

Most Americans say that cancer is one of the most feared diseases, and they fully support research that advances the march to a cure, recent marketing studies by the National Cancer Institute (NCI) show. But the studies also suggest that most people know little about what science has achieved, how research is done, or why certain projects are funded. OUTREACH: NCI director Richard Klausner has won praise for defending the peer-review system to the public and politicians. Concerned about resear

Written byStephen Hoffert
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Most Americans say that cancer is one of the most feared diseases, and they fully support research that advances the march to a cure, recent marketing studies by the National Cancer Institute (NCI) show. But the studies also suggest that most people know little about what science has achieved, how research is done, or why certain projects are funded.

OUTREACH: NCI director Richard Klausner has won praise for defending the peer-review system to the public and politicians. Concerned about research racing ahead of scientific literacy, NCI has published Cancer Research: Because Lives Depend On It, a collection of six brochures, as part of a campaign aimed at increasing public understanding of medical research. The information package will be distributed to all researchers, physicians, and health professionals who request it. NCI also provides suggestions on how to distribute the material to patients, communicate with the media, and organize public education and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies